Details for Patent: 8,092,832

Which drugs does patent 8,092,832 protect, and when does it expire?

Patent 8,092,832 protects FENTORA and is included in one NDA.

This patent has sixty-four patent family members in twenty-nine countries.

Summary for Patent: 8,092,832

Title:	Generally linear effervescent oral fentanyl dosage form and methods of administering
Abstract:	Fentanyl containing dosage forms and methods using same are described. These dosage forms include substantially less fentanyl by weight than know oral formulation and have advantages in terms of cost and side effects. These dosage forms are intended for oral administration of fentanyl across the oral mucosa.
Inventor(s):	Moe; Derek (Maple Grove, MN), Agarwal; Vikas (Plymouth, MN), Habib; Walib (Crystal, MN)
Assignee:	Cephalon, Inc. (Frazer, PA)
Application Number:	12/955,229
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,092,832
Patent Claim Types: see list of patent claims	Compound; Dosage form; Delivery;

Drugs Protected by US Patent 8,092,832

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Cephalon	FENTORA	fentanyl citrate	TABLET;BUCCAL, SUBLINGUAL	021947-001	Sep 25, 2006		DISCN	Yes	No			Y
Cephalon	FENTORA	fentanyl citrate	TABLET;BUCCAL, SUBLINGUAL	021947-002	Sep 25, 2006		DISCN	Yes	No			Y
Cephalon	FENTORA	fentanyl citrate	TABLET;BUCCAL, SUBLINGUAL	021947-003	Sep 25, 2006		DISCN	Yes	No			Y

International Family Members for US Patent 8,092,832

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	047999
Argentina	048000
Argentina	048029